Clinical Trial Update: Ondansetron, Alcohol Use, and Alcohol-Related Symptoms In HIV+ Persons [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluate ondansetron for reducing alcohol use and related symptoms in HIV-positive individuals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• HIV Infection

Drugs mentioned

• Ondansetron (ondansetron)

Snippet

Sponsor: Johns Hopkins University | Conditions: Alcohol Abuse, Alcohol Dependence | Phase 2 | Status: COMPLETED | Results posted: 2018-04-17